Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current and Future Treatment Landscape for Idiopathic Pulmonary Fibrosis
Francesco Bonella, Paolo Spagnolo, C.J. Ryerson
Drugs (2023) Vol. 83, Iss. 17, pp. 1581-1593
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Lung regeneration: diverse cell types and the therapeutic potential
Yutian Chen, Zhen Li, Gaili Ji, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 11
Highlights on Future Treatments of IPF: Clues and Pitfalls
Alessandro Libra, Enrico Sciacca, Giuseppe Muscato, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8392-8392
Open Access | Times Cited: 8
Idiopathic Pulmonary Fibrosis: From Common Microscopy to Single-Cell Biology and Precision Medicine
Moisés Selman, Annie Pardo
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 209, Iss. 9, pp. 1074-1081
Closed Access | Times Cited: 6
Novel therapeutic strategies and drugs for idiopathic pulmonary fibrosis
Zezhou Shi, Min Zhou, Jingfang Zhai, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 10
Closed Access | Times Cited: 5
Traditional Chinese Medicine Ion Introduction Therapy Reduces the Incidence of Acute Exacerbation of Idiopathic Pulmonary Fibrosis: A Prospective Cohort Study
Yan Wang, B. Xu, Jiajia Wang, et al.
International Journal of General Medicine (2025) Vol. Volume 18, pp. 21-32
Open Access
The role of the microbiota and metabolites in the treatment of pulmonary fibrosis with UC-MSCs: Integrating fecal metabolomics and 16S rDNA analysis
Yukai Luo, Shuang Zhou, Xiaojing Zhang, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0313989-e0313989
Open Access
An FGF2-Derived Short Peptide Attenuates Bleomycin-Induced Pulmonary Fibrosis by Inhibiting Collagen Deposition and Epithelial–Mesenchymal Transition via the FGFR/MAPK Signaling Pathway
Mengwei Wang, Yuanmeng Sun, Yanzhi Zhao, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 517-517
Open Access
Genetic variation reveals the therapeutic potential of BRSK2 in idiopathic pulmonary fibrosis
Zhe Chen, Mimi L.K. Tang, Nan Wang, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
Single-cell transcriptome analysis revealing mechanotransduction via the Hippo/YAP pathway in promoting fibroblast-to-myofibroblast transition and idiopathic pulmonary fibrosis development
Jiaqi Lu, Zhenhua Wang, Liguo Zhang
Gene (2025) Vol. 943, pp. 149271-149271
Closed Access
Role of Macrophage in Pathogenesis of Pulmonary Fibrosis: A Review
M. Hasan, Xuan Zhang
Advances in Lung Cancer (2025) Vol. 14, Iss. 01, pp. 1-17
Open Access
FBR2 modulates ferroptosis via the SIRT3/p53 pathway to ameliorate pulmonary fibrosis
Yu Cheng, Yang Jiao, Wan Wei, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Noscapine Derivative 428 Suppresses Ferroptosis Through Targeting Gpx4
Yufeng Wu, Youping Zhang, Haoliang Shi, et al.
(2025)
Closed Access
Premature ageing of lung alveoli and bone marrow cells from Terc deficient mice with different telomere lengths
Rosa Guerrero, Cristina Manguán-García, Carlos Carrascoso-Rubio, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Mechanisms and Therapeutic Potential of Myofibroblast Transformation in Pulmonary Fibrosis
Tianming Zhao, Yunchao Su
Deleted Journal (2025) Vol. 2, Iss. 1, pp. 10001-10001
Closed Access
Genetic insights into idiopathic pulmonary fibrosis: a multi-omics approach to identify potential therapeutic targets
Zhuofeng Wen, Wenpeng Liang, Zhongxia Yang, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Activin A Inhibitory Peptides Suppress Fibrotic Pathways by Targeting Epithelial–Mesenchymal Transition and Fibroblast–Myofibroblast Transformation in Idiopathic Pulmonary Fibrosis
Víctor Alexandre Félix Bastos, Patrícia Tiemi Fujimura, Aline Gomes de Souza, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2705-2705
Open Access
A Novel Polysaccharide from the Flowers of Lilium lancifolium Alleviates Pulmonary Fibrosis In Vivo and In Vitro
R.P. Liu, Tong Wu, Wanqi Zhou, et al.
Journal of Agricultural and Food Chemistry (2025)
Closed Access
Combination therapy blocking TNF superfamily members 14 and 15 reverses pulmonary fibrosis
Hope Steele, Ashley Willicut, Garrison Dell, et al.
The Journal of Immunology (2025)
Closed Access
Nintedanib loaded iron (III) chelated melanin nanoparticles as an MRI-visible antifibrotic drug delivery system
Emirhan Bayrak, Ece Bayır, Engin Baysoy, et al.
Colloids and Surfaces B Biointerfaces (2025), pp. 114652-114652
Closed Access
Inhibition of Rho GEFs attenuates pulmonary fibrosis through suppressing myofibroblast activation and reprogramming profibrotic macrophages
Chengju Luo, Chenqi Huang, Yuqi Zhu, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Noscapine derivative 428 suppresses ferroptosis through targeting GPX4
Youping Zhang, Haoliang Shi, Yingying Wang, et al.
Redox Biology (2025), pp. 103635-103635
Open Access
Anti-fibrotic Effects of Saengmaek-San, a Prescription of Traditional Korean Medicine in Bleomycin-Induced Pulmonary Fibrosis Mice Model
Donghyun Lee, Jeong-Won Shin, Eui-Joong Kim, et al.
Journal of Ethnopharmacology (2025), pp. 119866-119866
Closed Access
Emodin nanocrystals enhanced mucus penetration and ameliorated bleomycin-induced pulmonary fibrosis by pulmonary delivery
Chenghao Zhang, Yihua Wang, Xinran Cui, et al.
Journal of drug targeting (2025), pp. 1-17
Closed Access
Mechanisms of pulmonary fibrosis and lung cancer induced by chronic PM2.5 exposure: Focus on the airway epithelial barrier and epithelial-mesenchymal transition
Yu Shi, Qi Shao, Zilin Ren, et al.
Ecotoxicology and Environmental Safety (2025) Vol. 297, pp. 118253-118253
Closed Access
Protein Ubiquitination Modification in Pulmonary Fibrosis
Jinping Shen, Yuling Jiang, Wenxia Bu, et al.
Comprehensive physiology (2025) Vol. 15, Iss. 3
Closed Access
Page 1 - Next Page

Scroll to top